It was suggested that the inhibitory Siglec-3 (CD33) and Siglec-8 as well as the microglia-derived Siglec-F share the same ligand in the brain potentially contributing to Alzheimer’s disease (8). This evidence concerns the gene CD33 and early-onset autosomal dominant Alzheimer disease.